The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: A propensity score-matched analysis

Neurocritical Care

Volumn 19, Issue 2, 2013, Pages 140-149

  Ibrahim, George M ^a,b,c   Macdonald, R Loch ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Fluid balance; Hemodynamic therapy; HHH; Subarachnoid hemorrhage; Triple H; Vasospasm; Volume expansion

Indexed keywords

ALBUMIN; CLAZOSENTAN; DEXTRAN; STARCH;

ADULT; ANGIOGRAPHY; ARTICLE; BRAIN VASOSPASM; COHORT ANALYSIS; COLLOID; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; DELAYED ISCHEMIC NEUROLOGICAL DEFICIT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUID BALANCE; FLUID INTAKE; GLASGOW COMA SCALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER; TREATMENT RESPONSE;

AGED; CEREBRAL INFARCTION; COLLOIDS; CRITICAL CARE; DIOXANES; DOUBLE-BLIND METHOD; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROSPECTIVE STUDIES; PYRIDINES; PYRIMIDINES; RECEPTOR, ENDOTHELIN A; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; SULFONAMIDES; TETRAZOLES; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL; WATER-ELECTROLYTE BALANCE;

EID: 84885174036     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9860-z     Document Type: Article

References (38)

1. Rinkel GJ. Medical management of patients with aneurysmal subarachnoid haemorrhage. Int J Stroke. 2008;3:193-204. doi: 10.1111/j.1747-4949.2008.00210. x.
2. Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care. 2009;15:83-6. doi: 10.1097/MCC.0b013e32832922d1.
3. Thomas DJ, Marshall J, Russell RW, Wetherley-Mein G, du Boulay GH, Pearson TC, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet. 1977;2:941-3.
4. Tu YK, Kuo MF, Liu HM. Cerebral oxygen transport and metabolism during graded isovolemic hemodilution in experimental global ischemia. J Neurol Sci. 1997;150:115-22.
5. Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35:1844-51. doi: 10.1097/01.CCM.0000275392.08410.DD.
6. Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology. 2000;55:258-65.
7. Rinkel GJ, Feigin VL, Algra A, van Gijn J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2004;8(4):CD000483. doi: 10.1002/14651858.CD000483.pub2.
8. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007-17.
9. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98:978-84. doi: 10.3171/jns.2003.98.5.0978.
10. Brandt S, Regueira T, Bracht H, Porta F, Djafarzadeh S, Takala J, et al. Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care. 2009;13:R186. doi: 10.1186/cc8179;10.1186/cc8179.
11. Sakr Y, Vincent JL, Reinhart K, Groeneveld J, Michalopoulos A, Sprung CL, et al. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest. 2005;128:3098-108. doi: 10.1378/chest.128.5.3098.
12. Klein MB, Hayden D, Elson C, Nathens AB, Gamelli RL, Gibran NS, et al. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg. 2007;245:622-8. doi: 10.1097/01.sla.0000252572. 50684.49.
13. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015-21. doi: 10.1161/STROKEAHA.108.519942.
14. Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.
15. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-70.
16. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573-85.
17. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044-54.
18. Hijdra A, Brouwers PJ, Vermeulen M, van Gijn J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156-61.
19. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed tomographic diagnosis of intraventricular hemorrhage. Etiol progn Radiol. 1982;143:91-6.
20. LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR. Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery. 1992;31:678-84 discussion 684-5.
21. Ibrahim GM, Weidauer S, Vatter H, Raabe A, Macdonald RL. Attributing hypodensities on CT to angiographic vasospasm is not sensitive and unreliable. Stroke. 2012;43:109-12. doi: 10.1161/STROKEAHA.111.632745.
22. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-63.
23. Ibrahim GM, Vachhrajani S, Ilodigwe D, Stat M, Kassell NF, Mayer SA, et al. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2011;. doi: 10.1227/NEU. 0b013e31822e5a8e.
24. Ho D, Imai K, King G, Stuart E. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Anal. 2007;15:199-236.
25. D Ho K Imai, G King, E Stuart (2007) Matchit: Nonparametric preprocessing for parametric causal inference. Journal of Statistical Software.
26. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J, et al. pROC: an open source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
27. Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2005;103:974-81. doi: 10.3171/jns.2005.103.6.0974.
28. Deans KJ, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, et al. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med. 2007;35:1509-16. doi: 10.1097/01.CCM.0000266584.40715.A6.
29. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383-91.
30. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593-605 discussion 605-6.
31. Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery. 1983;12:658-61.
32. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17:439-47. doi: 10.1038/nm.2333;10.1038/nm.2333.
33. Dreier JP, Major S, Pannek HW, Woitzik J, Scheel M, Wiesenthal D, et al. Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain. 2012;135:259-75. doi: 10.1093/brain/awr303.
34. Suzuki S, Suzuki M, Iwabuchi T, Kamata Y. Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report. Neurosurgery. 1983;13:199-203.
35. Martini RP, Deem S, Brown M, Souter MJ, Yanez ND, Daniel S, et al. The association between fluid balance and outcomes after subarachnoid hemorrhage. Neurocrit Care. 2012;17:191-8. doi: 10.1007/s12028-011-9573-0.
36. Hoff RG, van Dijk GW, Algra A, Kalkman CJ, Rinkel GJ. Fluid balance and blood volume measurement after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;8:391-7. doi: 10.1007/s12028-007-9043-x.
37. Hoff R, Rinkel G, Verweij B, Algra A, Kalkman C. Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid hemorrhage: a prospective controlled study. Stroke. 2009;40:2575-7. doi: 10.1161/STROKEAHA.108.538116.
38. Ibrahim GM, Weidauer S, Macdonald RL. Interobserver variability in the interpretation of computed tomography following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2011;115:1191-6. doi: 10.3171/2011.7.JNS11725.